Michigan State University and Stanford University scientists have invented a nanoparticle that eats away—from the inside out—portions of plaques that cause heart attacks.
Bio & Medicine
Jan 28, 2020
3
2034
Atherosclerosis, a disease in which plaque builds up inside arteries, is a prolific and invisible killer, but it may soon lose its ability to hide in the body and wreak havoc. Scientists have now developed a nanoparticle ...
Bio & Medicine
Mar 13, 2016
0
493
Nanometer-sized "drones" that deliver a special type of healing molecule to fat deposits in arteries could become a new way to prevent heart attacks caused by atherosclerosis, according to a study in pre-clinical models by ...
Bio & Medicine
Feb 18, 2015
0
725
Researchers at Ben-Gurion University (BGU) and the Sheba Medical Center have developed a new therapy to treat atherosclerosis and prevent heart failure with a new biomedical polymer that reduces arterial plaque and inflammation ...
Bio & Medicine
May 22, 2017
1
368
Scientists and engineers at UC Santa Barbara and other researchers have developed a nanoparticle that can attack plaque -- a major cause of cardiovascular disease. The new development is described in a recent issue of the ...
Bio & Medicine
Jun 4, 2009
0
0
Skoltech researchers and their colleagues have come one step closer to a working optoacoustic endoscopic probe—a device that could slip inside a blood vessel and analyze atherosclerotic plaques by shining laser light on ...
Optics & Photonics
Dec 3, 2021
0
45
Cardiovascular disease, which kills one Australian every 12 minutes, is caused by a hardening of the arteries due to abnormal deposits of fat and cholesterol (known as plaque) in the inner lining of the artery; a process ...
Bio & Medicine
Jun 5, 2020
0
20
How can you trace a single diseased cell in an intact brain or a human heart? The search resembles looking for a needle in a haystack. The teams of Ali Ertürk at Helmholtz Munich and LMU Munich and Matthias Mann at the Max ...
Cell & Microbiology
Dec 22, 2022
0
112
Physicochemical cargo-switching nanoparticles (CSNP) designed by KAIST can help significantly reduce cholesterol and macrophage foam cells in arteries, which are the two main triggers for atherosclerotic plaque and inflammation.
Bio & Medicine
Jun 17, 2020
0
7
